“Centella extract” sounds like a single ingredient. In practice it can mean a pale purified madecassoside powder, a broad hydroalcoholic leaf extract or a dark botanical concentrate with only modest triterpene content. The INCI name identifies the plant; it does not standardise what the formula receives.
Four markers reveal the extract behind the label
The best-known Centella constituents are pentacyclic triterpenes collectively called centelloids. Madecassoside and asiaticoside are glycosides; madecassic acid and asiatic acid are their corresponding aglycones. Their relative abundance changes with genotype, geography, plant part, harvest and extraction.
A meaningful specification names the markers and the analytical method used to quantify them, commonly a suitable chromatographic assay. “Total triterpenes” can be useful, but only when the supplier explains which compounds are included and how the result is calculated. Otherwise, a nominal 10% result from one source may not be comparable with 10% from another.
Extraction decides more than concentration
Water, ethanol-water blends and other permitted extraction systems recover different chemical windows. Further fractionation can enrich glycosides or acids and remove chlorophyll, odour and insoluble plant material. Those choices affect formula colour, dispersibility, preservation needs and the evidence that can reasonably follow the ingredient.
Ask whether the commercial material is a native extract, an extract adjusted with a carrier, or a purified fraction. Record the drug-to-extract ratio where relevant, the plant part, extraction solvent, carrier percentage and marker assay. Without those fields, batch consistency is difficult to defend.
Read the skin literature at the right level
Centella and its triterpenes have substantial laboratory and preclinical literature around inflammatory signalling, collagen-related pathways, keratinocyte behaviour and wound models. Reviews also describe limited human evidence. That is biologically encouraging, but it does not automatically validate a therapeutic claim for a rinse-off cleanser or a low-dose face cream.
Cosmetic communication should match the finished-product evidence: support for skin comfort, hydration, barrier appearance or the look of stressed skin may be appropriate when tested. “Heals wounds” crosses into medical territory in many jurisdictions and ignores differences between purified research materials and commercial extracts.
Standardisation makes dose comparisons possible
Suppose Formula A uses 1% of an extract standardised to 2% combined markers, while Formula B uses 0.2% of a 90% purified centelloid fraction. The label percentages favour Formula A, but the second formula delivers far more assayed active. Comparing only use levels creates a false equivalence.
Calculate the delivered amount of each declared marker. Then confirm that the chosen level follows supplier safety and efficacy data for that grade. Colour, scent and marketing familiarity should not substitute for the assay.
Formulation starts with the commercial form
Purified glycosides, powdered extracts and liquid extracts behave differently. Check true solubility or dispersibility in the intended phase, sensitivity to pH and heat, interactions with electrolytes, and the contribution of the extract carrier to preservation. Run centrifuge, temperature-cycle and real-time tests; watch for sediment, haze and colour migration as well as viscosity change.
For purchasing, request botanical identity, country and plant part of origin, extraction solvent, extract ratio, carrier composition, chromatographic marker data, pesticide and heavy-metal limits, microbiology, CoA and SDS. Centella becomes reproducible only when its celebrated plant name is translated into measurable batch attributes.